30 November 2022
RUA Life Sciences Plc
("RUA Life Sciences", the "Company" or the "Group")
Investor Presentation - 12 December 2022
RUA Life Sciences plc (AIM: RUA.L), the holding company of a group of medical device businesses focused on the exploitation of the world leading long-term implantable biostable polyurethane (Elast-Eon™), is pleased to announce they will conduct an Investor Presentation which will follow the publication of the Group's interim results for the six-month period ended 30 September 2022.
The event will take place at 11.00am on Monday 12 December with Bill Brown (Chairman) and Caroline Stretton (Managing Director) presenting from the company.
The online presentation is open to all existing and potential shareholders. Questions can be submitted during the presentation to be addressed at the end.
To register for the event, please click here.
A recording of the presentation will be available shortly afterwards here.
For more information please contact:
Equity Development
Hannah Crowe / Matt Evans
020 7065 2692
|
|
| |
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
